AAOS: Definitive trial on impact of ultrasound in treatment of tibial fractures feasible .
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2013;1(2):242Exclusive Author Interview
Dr. Busse speaking on the impact of ultrasound treatment for tibial shaft fractures.
51 patients with operatively treated tibial shaft fractures were randomized to either receive low-intensity pulsed ultrasound (LIPUS) or treatment with a deactivated LIPUS device, to determine what the possibility of a definitive trial would be on assessing the impact of LIPUS on patient outcomes. After collecting over a 1 year period recruitment rates, data on patient compliance to treatment, follow-up rates, and data on investigators’ ability to follow study protocol, it was determined that this pilot study supported the probability of a definitive trial in the future.
Konferenzbericht
Dieser ACE-Bericht ist eine Zusammenfassung einer Konferenzpräsentation oder eines Abstracts. Aufgrund der zur Verfügung gestellten Informationen ist es nur begrenzt möglich, eine genaue Bewertung des Risikos von Verzerrungen oder der Gesamtqualität vorzunehmen. Bitte interpretieren Sie die Ergebnisse mit Vorsicht, da die Studien möglicherweise noch nicht abgeschlossen sind und ausgewählte Ergebnisse präsentiert wurden.
Warum wurde diese Studie jetzt benötigt?
Due to the nature of tibial fractures, a long recovery period is required. Low-intensity pulsed ultrasound (LIPUS) has been suggested as a treatment that may shorten the healing time. However, it is unclear as to what the impacts of LIPUS are on function. Hence, this study aimed to determine the likelihood of conducting a definitive trial in the future, which would assess the functional and clinical outcomes of LIPUS treatment on operatively treated tibial shaft fractures.
Was war die wichtigste Forschungsfrage?
What was the possibility of conducting a future definitive trial on the functional and clinical outcomes in patients receiving LIPUS treatment for operatively treated tibial shaft fractures, when measured over a 1 year period?
- The overall rate of recruitment for this pilot study was 0.8 patients per month, and 84% of patients (43) completed the 1 year follow-up.
- In the LIPUS group 39 patients (76%) fully complied with the use of the ultrasound device, while 12 patients (24%) displayed over 50% obedience to treatment.
- At the 6 month follow-up assessment, patients in the LIPUS group had significantly better SP-36 PCS scores (Mean difference: 6.6; 95% CI: 0.1 to 13.0; p=0.046) and HUI-III scores (Mean difference: 0.20; 95% CI: 0.01 to 0.39; p=0.035) than the Sham group.
- SMFA measures, radiographic healing time, malunion and nonunion rates, and operative and non-operative procedure rates did not differ significantly between groups.
- The tibia fractures that were at risk displayed significant hindrance in functional recovery compared to those fractures that were not at risk, at 9 and 12 months (9 months: p<0.001; 12 months: p=0.03).
Was sollte ich mir besonders merken?
High patient compliance rates and and full investigator adherence to study protocols in this study pilot supported the probability of a definitive trial in the future.
Wie wird sich dies auf die Behandlung meiner Patienten auswirken?
Currently a trial with a population size of 500 patients assessing the functional and clinical outcomes of LIPUS treatment on operatively treated tibial shaft fractures is being conducted. The results of that study when completed should be able to provide clarity on the effect of LIPUS on radiographic healing time, malunion and nonunion rates, and operative and non-operative procedure rates.
HAFTUNGSAUSSCHLUSS
Der Inhalt dieser Seite dient nur zu Informationszwecken und ist nicht als Ersatz für professionelle medizinische Beratung, Diagnose oder Behandlung gedacht. Wenn Sie eine medizinische Behandlung benötigen, wenden Sie sich immer an Ihren Arzt oder suchen Sie die nächstgelegene Notaufnahme auf. Die Meinungen, Überzeugungen und Standpunkte, die von den Personen auf dieser Seite geäußert werden, spiegeln nicht die Meinungen, Überzeugungen und Standpunkte von OrthoEvidence wider.
0 von 4 monatliche KOSTENLOSE Artikel freigeschaltet
